Table of Content

1 Semi-solid Dosage Market Overview
1.1 Semi-solid Dosage Product Overview
1.2 Semi-solid Dosage Market Segment by Type
1.2.1 Ointment
1.2.2 Paste
1.2.3 Plaster
1.2.4 Gel
1.3 Global Semi-solid Dosage Market Size by Type
1.3.1 Global Semi-solid Dosage Market Size Overview by Type (2018-2029)
1.3.2 Global Semi-solid Dosage Historic Market Size Review by Type (2018-2024)
1.3.3 Global Semi-solid Dosage Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Semi-solid Dosage Sales Breakdown by Type (2018-2024)
1.4.2 Europe Semi-solid Dosage Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Semi-solid Dosage Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Semi-solid Dosage Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Semi-solid Dosage Sales Breakdown by Type (2018-2024)
2 Global Semi-solid Dosage Market Competition by Company
2.1 Global Top Players by Semi-solid Dosage Sales (2018-2024)
2.2 Global Top Players by Semi-solid Dosage Revenue (2018-2024)
2.3 Global Top Players by Semi-solid Dosage Price (2018-2024)
2.4 Global Top Manufacturers Semi-solid Dosage Manufacturing Base Distribution, Sales Area, Product Type
2.5 Semi-solid Dosage Market Competitive Situation and Trends
2.5.1 Semi-solid Dosage Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Semi-solid Dosage Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Semi-solid Dosage as of 2022)
2.7 Date of Key Manufacturers Enter into Semi-solid Dosage Market
2.8 Key Manufacturers Semi-solid Dosage Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Semi-solid Dosage Status and Outlook by Region
3.1 Global Semi-solid Dosage Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Semi-solid Dosage Historic Market Size by Region
3.2.1 Global Semi-solid Dosage Sales in Volume by Region (2018-2024)
3.2.2 Global Semi-solid Dosage Sales in Value by Region (2018-2024)
3.2.3 Global Semi-solid Dosage Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Semi-solid Dosage Forecasted Market Size by Region
3.3.1 Global Semi-solid Dosage Sales in Volume by Region (2024-2029)
3.3.2 Global Semi-solid Dosage Sales in Value by Region (2024-2029)
3.3.3 Global Semi-solid Dosage Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Semi-solid Dosage by Application
4.1 Semi-solid Dosage Market Segment by Application
4.1.1 Skin
4.1.2 Nasal Cavity
4.1.3 Vaginal Cavity
4.1.4 Rectal Cavity
4.1.5 Others
4.2 Global Semi-solid Dosage Market Size by Application
4.2.1 Global Semi-solid Dosage Market Size Overview by Application (2018-2029)
4.2.2 Global Semi-solid Dosage Historic Market Size Review by Application (2018-2024)
4.2.3 Global Semi-solid Dosage Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Semi-solid Dosage Sales Breakdown by Application (2018-2024)
4.3.2 Europe Semi-solid Dosage Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Semi-solid Dosage Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Semi-solid Dosage Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Semi-solid Dosage Sales Breakdown by Application (2018-2024)
5 North America Semi-solid Dosage by Country
5.1 North America Semi-solid Dosage Historic Market Size by Country
5.1.1 North America Semi-solid Dosage Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Semi-solid Dosage Sales in Volume by Country (2018-2024)
5.1.3 North America Semi-solid Dosage Sales in Value by Country (2018-2024)
5.2 North America Semi-solid Dosage Forecasted Market Size by Country
5.2.1 North America Semi-solid Dosage Sales in Volume by Country (2024-2029)
5.2.2 North America Semi-solid Dosage Sales in Value by Country (2024-2029)
6 Europe Semi-solid Dosage by Country
6.1 Europe Semi-solid Dosage Historic Market Size by Country
6.1.1 Europe Semi-solid Dosage Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Semi-solid Dosage Sales in Volume by Country (2018-2024)
6.1.3 Europe Semi-solid Dosage Sales in Value by Country (2018-2024)
6.2 Europe Semi-solid Dosage Forecasted Market Size by Country
6.2.1 Europe Semi-solid Dosage Sales in Volume by Country (2024-2029)
6.2.2 Europe Semi-solid Dosage Sales in Value by Country (2024-2029)
7 Asia-Pacific Semi-solid Dosage by Region
7.1 Asia-Pacific Semi-solid Dosage Historic Market Size by Region
7.1.1 Asia-Pacific Semi-solid Dosage Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Semi-solid Dosage Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Semi-solid Dosage Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Semi-solid Dosage Forecasted Market Size by Region
7.2.1 Asia-Pacific Semi-solid Dosage Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Semi-solid Dosage Sales in Value by Region (2024-2029)
8 Latin America Semi-solid Dosage by Country
8.1 Latin America Semi-solid Dosage Historic Market Size by Country
8.1.1 Latin America Semi-solid Dosage Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Semi-solid Dosage Sales in Volume by Country (2018-2024)
8.1.3 Latin America Semi-solid Dosage Sales in Value by Country (2018-2024)
8.2 Latin America Semi-solid Dosage Forecasted Market Size by Country
8.2.1 Latin America Semi-solid Dosage Sales in Volume by Country (2024-2029)
8.2.2 Latin America Semi-solid Dosage Sales in Value by Country (2024-2029)
9 Middle East and Africa Semi-solid Dosage by Country
9.1 Middle East and Africa Semi-solid Dosage Historic Market Size by Country
9.1.1 Middle East and Africa Semi-solid Dosage Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Semi-solid Dosage Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Semi-solid Dosage Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Semi-solid Dosage Forecasted Market Size by Country
9.2.1 Middle East and Africa Semi-solid Dosage Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Semi-solid Dosage Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Semi-solid Dosage Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Merck & Co
10.2.1 Merck & Co Company Information
10.2.2 Merck & Co Introduction and Business Overview
10.2.3 Merck & Co Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co Semi-solid Dosage Products Offered
10.2.5 Merck & Co Recent Development
10.3 Bayer AG
10.3.1 Bayer AG Company Information
10.3.2 Bayer AG Introduction and Business Overview
10.3.3 Bayer AG Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer AG Semi-solid Dosage Products Offered
10.3.5 Bayer AG Recent Development
10.4 Hisamitsu Pharmaceutical
10.4.1 Hisamitsu Pharmaceutical Company Information
10.4.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Products Offered
10.4.5 Hisamitsu Pharmaceutical Recent Development
10.5 Glenmark Pharmaceuticals
10.5.1 Glenmark Pharmaceuticals Company Information
10.5.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Products Offered
10.5.5 Glenmark Pharmaceuticals Recent Development
10.6 Cipla Ltd
10.6.1 Cipla Ltd Company Information
10.6.2 Cipla Ltd Introduction and Business Overview
10.6.3 Cipla Ltd Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Ltd Semi-solid Dosage Products Offered
10.6.5 Cipla Ltd Recent Development
10.7 Nestle SA
10.7.1 Nestle SA Company Information
10.7.2 Nestle SA Introduction and Business Overview
10.7.3 Nestle SA Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Nestle SA Semi-solid Dosage Products Offered
10.7.5 Nestle SA Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Introduction and Business Overview
10.8.3 Novartis AG Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis AG Semi-solid Dosage Products Offered
10.8.5 Novartis AG Recent Development
10.9 GlaxoSmithKline plc
10.9.1 GlaxoSmithKline plc Company Information
10.9.2 GlaxoSmithKline plc Introduction and Business Overview
10.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline plc Semi-solid Dosage Products Offered
10.9.5 GlaxoSmithKline plc Recent Development
10.10 Bausch Health Companies
10.10.1 Bausch Health Companies Company Information
10.10.2 Bausch Health Companies Introduction and Business Overview
10.10.3 Bausch Health Companies Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bausch Health Companies Semi-solid Dosage Products Offered
10.10.5 Bausch Health Companies Recent Development
10.11 Allergan
10.11.1 Allergan Company Information
10.11.2 Allergan Introduction and Business Overview
10.11.3 Allergan Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Allergan Semi-solid Dosage Products Offered
10.11.5 Allergan Recent Development
10.12 Biofrontera
10.12.1 Biofrontera Company Information
10.12.2 Biofrontera Introduction and Business Overview
10.12.3 Biofrontera Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Biofrontera Semi-solid Dosage Products Offered
10.12.5 Biofrontera Recent Development
10.13 Crown Laboratories
10.13.1 Crown Laboratories Company Information
10.13.2 Crown Laboratories Introduction and Business Overview
10.13.3 Crown Laboratories Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Crown Laboratories Semi-solid Dosage Products Offered
10.13.5 Crown Laboratories Recent Development
10.14 Akorn
10.14.1 Akorn Company Information
10.14.2 Akorn Introduction and Business Overview
10.14.3 Akorn Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Akorn Semi-solid Dosage Products Offered
10.14.5 Akorn Recent Development
10.15 Ingenus Pharmaceuticals
10.15.1 Ingenus Pharmaceuticals Company Information
10.15.2 Ingenus Pharmaceuticals Introduction and Business Overview
10.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Products Offered
10.15.5 Ingenus Pharmaceuticals Recent Development
10.16 Sun Pharmaceuticals
10.16.1 Sun Pharmaceuticals Company Information
10.16.2 Sun Pharmaceuticals Introduction and Business Overview
10.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sun Pharmaceuticals Semi-solid Dosage Products Offered
10.16.5 Sun Pharmaceuticals Recent Development
10.17 Crescita Therapeutics
10.17.1 Crescita Therapeutics Company Information
10.17.2 Crescita Therapeutics Introduction and Business Overview
10.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Crescita Therapeutics Semi-solid Dosage Products Offered
10.17.5 Crescita Therapeutics Recent Development
10.18 Mylan N.V.
10.18.1 Mylan N.V. Company Information
10.18.2 Mylan N.V. Introduction and Business Overview
10.18.3 Mylan N.V. Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Mylan N.V. Semi-solid Dosage Products Offered
10.18.5 Mylan N.V. Recent Development
10.19 Encore Dermatology
10.19.1 Encore Dermatology Company Information
10.19.2 Encore Dermatology Introduction and Business Overview
10.19.3 Encore Dermatology Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Encore Dermatology Semi-solid Dosage Products Offered
10.19.5 Encore Dermatology Recent Development
10.20 LEO Pharma
10.20.1 LEO Pharma Company Information
10.20.2 LEO Pharma Introduction and Business Overview
10.20.3 LEO Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.20.4 LEO Pharma Semi-solid Dosage Products Offered
10.20.5 LEO Pharma Recent Development
10.21 Almirall, S.A
10.21.1 Almirall, S.A Company Information
10.21.2 Almirall, S.A Introduction and Business Overview
10.21.3 Almirall, S.A Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Almirall, S.A Semi-solid Dosage Products Offered
10.21.5 Almirall, S.A Recent Development
10.22 Aclaris Therapeutics
10.22.1 Aclaris Therapeutics Company Information
10.22.2 Aclaris Therapeutics Introduction and Business Overview
10.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Aclaris Therapeutics Semi-solid Dosage Products Offered
10.22.5 Aclaris Therapeutics Recent Development
10.23 Taro Pharmaceutical Industries
10.23.1 Taro Pharmaceutical Industries Company Information
10.23.2 Taro Pharmaceutical Industries Introduction and Business Overview
10.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Products Offered
10.23.5 Taro Pharmaceutical Industries Recent Development
10.24 Teligent Pharma
10.24.1 Teligent Pharma Company Information
10.24.2 Teligent Pharma Introduction and Business Overview
10.24.3 Teligent Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Teligent Pharma Semi-solid Dosage Products Offered
10.24.5 Teligent Pharma Recent Development
10.25 Perrigo Pharma
10.25.1 Perrigo Pharma Company Information
10.25.2 Perrigo Pharma Introduction and Business Overview
10.25.3 Perrigo Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Perrigo Pharma Semi-solid Dosage Products Offered
10.25.5 Perrigo Pharma Recent Development
10.26 SigmaAldrich
10.26.1 SigmaAldrich Company Information
10.26.2 SigmaAldrich Introduction and Business Overview
10.26.3 SigmaAldrich Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
10.26.4 SigmaAldrich Semi-solid Dosage Products Offered
10.26.5 SigmaAldrich Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Semi-solid Dosage Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Semi-solid Dosage Industrial Chain Analysis
11.4 Semi-solid Dosage Market Dynamics
11.4.1 Semi-solid Dosage Industry Trends
11.4.2 Semi-solid Dosage Market Drivers
11.4.3 Semi-solid Dosage Market Challenges
11.4.4 Semi-solid Dosage Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Semi-solid Dosage Distributors
12.3 Semi-solid Dosage Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ointment
Table 2. Major Company of Paste
Table 3. Major Company of Plaster
Table 4. Major Company of Gel
Table 5. Global Semi-solid Dosage Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Semi-solid Dosage Sales by Type (2018-2024) & (K Units)
Table 7. Global Semi-solid Dosage Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Semi-solid Dosage Sales by Type (2018-2024) & (US& Million)
Table 9. Global Semi-solid Dosage Market Share in Value by Type (2018-2024)
Table 10. Global Semi-solid Dosage Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Semi-solid Dosage Sales by Type (2024-2029) & (K Units)
Table 12. Global Semi-solid Dosage Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Semi-solid Dosage Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Semi-solid Dosage Sales Market Share in Value by Type (2024-2029)
Table 15. Global Semi-solid Dosage Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Semi-solid Dosage Sales by Type (2018-2024) & (K Units)
Table 17. North America Semi-solid Dosage Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Semi-solid Dosage Sales (K Units) by Type (2018-2024)
Table 19. Europe Semi-solid Dosage Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Semi-solid Dosage Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Semi-solid Dosage Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Semi-solid Dosage Sales (K Units) by Type (2018-2024)
Table 23. Latin America Semi-solid Dosage Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Semi-solid Dosage Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Semi-solid Dosage Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Semi-solid Dosage Sales by Company (2018-2024) & (K Units)
Table 27. Global Semi-solid Dosage Sales Share by Company (2018-2024)
Table 28. Global Semi-solid Dosage Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Semi-solid Dosage Revenue Share by Company (2018-2024)
Table 30. Global Market Semi-solid Dosage Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Semi-solid Dosage Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Semi-solid Dosage Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Semi-solid Dosage as of 2022)
Table 34. Date of Key Manufacturers Enter into Semi-solid Dosage Market
Table 35. Key Manufacturers Semi-solid Dosage Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Semi-solid Dosage Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Semi-solid Dosage Sales by Region (2018-2024) & (K Units)
Table 39. Global Semi-solid Dosage Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Semi-solid Dosage Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Semi-solid Dosage Sales Market Share in Value by Region (2018-2024)
Table 42. Global Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Semi-solid Dosage Sales by Region (2024-2029) & (K Units)
Table 44. Global Semi-solid Dosage Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Semi-solid Dosage Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Semi-solid Dosage Sales Market Share in Value by Region (2024-2029)
Table 47. Global Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Semi-solid Dosage Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Semi-solid Dosage Sales by Application (2018-2024) & (K Units)
Table 50. Global Semi-solid Dosage Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Semi-solid Dosage Sales Market Share in Value by Application (2018-2024)
Table 53. Global Semi-solid Dosage Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Semi-solid Dosage Sales by Application (2024-2029) & (K Units)
Table 55. Global Semi-solid Dosage Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Semi-solid Dosage Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Semi-solid Dosage Sales Market Share in Value by Application (2024-2029)
Table 58. Global Semi-solid Dosage Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Semi-solid Dosage Sales by Application (2018-2024) (K Units)
Table 60. North America Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Semi-solid Dosage Sales by Application (2018-2024) (K Units)
Table 62. Europe Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Semi-solid Dosage Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Semi-solid Dosage Sales by Application (2018-2024) (K Units)
Table 66. Latin America Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Semi-solid Dosage Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Semi-solid Dosage Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 70. North America Semi-solid Dosage Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Semi-solid Dosage Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Semi-solid Dosage Sales Market Share in Value by Country (2018-2024)
Table 73. North America Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 74. North America Semi-solid Dosage Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Semi-solid Dosage Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Semi-solid Dosage Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 78. Europe Semi-solid Dosage Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Semi-solid Dosage Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Semi-solid Dosage Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 82. Europe Semi-solid Dosage Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Semi-solid Dosage Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Semi-solid Dosage Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Semi-solid Dosage Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Semi-solid Dosage Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Semi-solid Dosage Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Semi-solid Dosage Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Semi-solid Dosage Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Semi-solid Dosage Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Semi-solid Dosage Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Semi-solid Dosage Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Semi-solid Dosage Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Semi-solid Dosage Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Semi-solid Dosage Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Semi-solid Dosage Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Semi-solid Dosage Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Semi-solid Dosage Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Semi-solid Dosage Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Semi-solid Dosage Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Semi-solid Dosage Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Semi-solid Dosage Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Semi-solid Dosage Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Semi-solid Dosage Sales Market Share in Value by Country (2024-2029)
Table 109. Johnson & Johnson Company Information
Table 110. Johnson & Johnson Introduction and Business Overview
Table 111. Johnson & Johnson Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Johnson & Johnson Semi-solid Dosage Product
Table 113. Johnson & Johnson Recent Development
Table 114. Merck & Co Company Information
Table 115. Merck & Co Introduction and Business Overview
Table 116. Merck & Co Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Merck & Co Semi-solid Dosage Product
Table 118. Merck & Co Recent Development
Table 119. Bayer AG Company Information
Table 120. Bayer AG Introduction and Business Overview
Table 121. Bayer AG Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Bayer AG Semi-solid Dosage Product
Table 123. Bayer AG Recent Development
Table 124. Hisamitsu Pharmaceutical Company Information
Table 125. Hisamitsu Pharmaceutical Introduction and Business Overview
Table 126. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Hisamitsu Pharmaceutical Semi-solid Dosage Product
Table 128. Hisamitsu Pharmaceutical Recent Development
Table 129. Glenmark Pharmaceuticals Company Information
Table 130. Glenmark Pharmaceuticals Introduction and Business Overview
Table 131. Glenmark Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Glenmark Pharmaceuticals Semi-solid Dosage Product
Table 133. Glenmark Pharmaceuticals Recent Development
Table 134. Cipla Ltd Company Information
Table 135. Cipla Ltd Introduction and Business Overview
Table 136. Cipla Ltd Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Cipla Ltd Semi-solid Dosage Product
Table 138. Cipla Ltd Recent Development
Table 139. Nestle SA Company Information
Table 140. Nestle SA Introduction and Business Overview
Table 141. Nestle SA Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Nestle SA Semi-solid Dosage Product
Table 143. Nestle SA Recent Development
Table 144. Novartis AG Company Information
Table 145. Novartis AG Introduction and Business Overview
Table 146. Novartis AG Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Novartis AG Semi-solid Dosage Product
Table 148. Novartis AG Recent Development
Table 149. GlaxoSmithKline plc Company Information
Table 150. GlaxoSmithKline plc Introduction and Business Overview
Table 151. GlaxoSmithKline plc Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. GlaxoSmithKline plc Semi-solid Dosage Product
Table 153. GlaxoSmithKline plc Recent Development
Table 154. Bausch Health Companies Company Information
Table 155. Bausch Health Companies Introduction and Business Overview
Table 156. Bausch Health Companies Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Bausch Health Companies Semi-solid Dosage Product
Table 158. Bausch Health Companies Recent Development
Table 159. Allergan Company Information
Table 160. Allergan Introduction and Business Overview
Table 161. Allergan Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Allergan Semi-solid Dosage Product
Table 163. Allergan Recent Development
Table 164. Biofrontera Company Information
Table 165. Biofrontera Introduction and Business Overview
Table 166. Biofrontera Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Biofrontera Semi-solid Dosage Product
Table 168. Biofrontera Recent Development
Table 169. Crown Laboratories Company Information
Table 170. Crown Laboratories Introduction and Business Overview
Table 171. Crown Laboratories Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Crown Laboratories Semi-solid Dosage Product
Table 173. Crown Laboratories Recent Development
Table 174. Akorn Company Information
Table 175. Akorn Introduction and Business Overview
Table 176. Akorn Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Akorn Semi-solid Dosage Product
Table 178. Akorn Recent Development
Table 179. Ingenus Pharmaceuticals Company Information
Table 180. Ingenus Pharmaceuticals Introduction and Business Overview
Table 181. Ingenus Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Ingenus Pharmaceuticals Semi-solid Dosage Product
Table 183. Ingenus Pharmaceuticals Recent Development
Table 184. Sun Pharmaceuticals Company Information
Table 185. Sun Pharmaceuticals Introduction and Business Overview
Table 186. Sun Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Sun Pharmaceuticals Semi-solid Dosage Product
Table 188. Sun Pharmaceuticals Recent Development
Table 189. Crescita Therapeutics Company Information
Table 190. Crescita Therapeutics Introduction and Business Overview
Table 191. Crescita Therapeutics Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 192. Crescita Therapeutics Semi-solid Dosage Product
Table 193. Crescita Therapeutics Recent Development
Table 194. Mylan N.V. Company Information
Table 195. Mylan N.V. Introduction and Business Overview
Table 196. Mylan N.V. Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 197. Mylan N.V. Semi-solid Dosage Product
Table 198. Mylan N.V. Recent Development
Table 199. Encore Dermatology Company Information
Table 200. Encore Dermatology Introduction and Business Overview
Table 201. Encore Dermatology Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 202. Encore Dermatology Semi-solid Dosage Product
Table 203. Encore Dermatology Recent Development
Table 204. LEO Pharma Company Information
Table 205. LEO Pharma Introduction and Business Overview
Table 206. LEO Pharma Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 207. LEO Pharma Semi-solid Dosage Product
Table 208. LEO Pharma Recent Development
Table 209. Almirall, S.A Company Information
Table 210. Almirall, S.A Introduction and Business Overview
Table 211. Almirall, S.A Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 212. Almirall, S.A Semi-solid Dosage Product
Table 213. Almirall, S.A Recent Development
Table 214. Aclaris Therapeutics Company Information
Table 215. Aclaris Therapeutics Introduction and Business Overview
Table 216. Aclaris Therapeutics Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 217. Aclaris Therapeutics Semi-solid Dosage Product
Table 218. Aclaris Therapeutics Recent Development
Table 219. Taro Pharmaceutical Industries Company Information
Table 220. Taro Pharmaceutical Industries Introduction and Business Overview
Table 221. Taro Pharmaceutical Industries Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 222. Taro Pharmaceutical Industries Semi-solid Dosage Product
Table 223. Taro Pharmaceutical Industries Recent Development
Table 224. Teligent Pharma Company Information
Table 225. Teligent Pharma Introduction and Business Overview
Table 226. Teligent Pharma Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 227. Teligent Pharma Semi-solid Dosage Product
Table 228. Teligent Pharma Recent Development
Table 229. Perrigo Pharma Introduction and Business Overview
Table 230. Perrigo Pharma Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 231. Perrigo Pharma Semi-solid Dosage Product
Table 232. Perrigo Pharma Recent Development
Table 233. Perrigo Pharma Company Information
Table 234. SigmaAldrich Company Information
Table 235. SigmaAldrich Introduction and Business Overview
Table 236. SigmaAldrich Semi-solid Dosage Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 237. SigmaAldrich Semi-solid Dosage Product
Table 238. SigmaAldrich Recent Development
Table 239. Key Raw Materials Lists
Table 240. Raw Materials Key Suppliers Lists
Table 241. Semi-solid Dosage Market Trends
Table 242. Semi-solid Dosage Market Drivers
Table 243. Semi-solid Dosage Market Challenges
Table 244. Semi-solid Dosage Market Restraints
Table 245. Semi-solid Dosage Distributors List
Table 246. Semi-solid Dosage Downstream Customers
Table 247. Research Programs/Design for This Report
Table 248. Key Data Information from Secondary Sources
Table 249. Key Data Information from Primary Sources
List of Figures
Figure 1. Semi-solid Dosage Product Picture
Figure 2. Global Semi-solid Dosage Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Semi-solid Dosage Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Semi-solid Dosage Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Ointment
Figure 6. Global Ointment Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Paste
Figure 8. Global Paste Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Plaster
Figure 10. Global Plaster Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Gel
Figure 12. Global Gel Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Semi-solid Dosage Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Semi-solid Dosage Sales Market Share by Type in 2022 & 2029
Figure 15. North America Semi-solid Dosage Sales Market Share in Volume by Type in 2022
Figure 16. North America Semi-solid Dosage Sales Market Share in Value by Type in 2022
Figure 17. Europe Semi-solid Dosage Sales Market Share in Volume by Type in 2022
Figure 18. Europe Semi-solid Dosage Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Semi-solid Dosage Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Semi-solid Dosage Sales Market Share in Value by Type in 2022
Figure 21. Latin America Semi-solid Dosage Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Semi-solid Dosage Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Semi-solid Dosage Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Semi-solid Dosage Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-solid Dosage Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-solid Dosage Revenue in 2022
Figure 27. Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Skin
Figure 29. Global Skin Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Nasal Cavity
Figure 31. Global Nasal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Vaginal Cavity
Figure 33. Global Vaginal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Rectal Cavity
Figure 35. Global Rectal Cavity Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Global Semi-solid Dosage Sales by Application (2018-2029) & (US$ Million)
Figure 39. Global Semi-solid Dosage Sales Market Share by Application in 2022 & 2029
Figure 40. North America Semi-solid Dosage Sales Market Share in Volume by Application in 2022
Figure 41. North America Semi-solid Dosage Sales Market Share in Value by Application in 2022
Figure 42. Europe Semi-solid Dosage Sales Market Share in Volume by Application in 2022
Figure 43. Europe Semi-solid Dosage Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Semi-solid Dosage Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Semi-solid Dosage Sales Market Share in Value by Application in 2022
Figure 46. Latin America Semi-solid Dosage Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Semi-solid Dosage Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Semi-solid Dosage Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Semi-solid Dosage Manufacturing Cost Structure
Figure 51. Semi-solid Dosage Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed